<DOC>
	<DOCNO>NCT01935726</DOCNO>
	<brief_summary>As name state , contact registry securely store contact information group reasonably well-characterized patient ( primary supporters/caregivers ) interest informed ongoing future research opportunity . Pulmonary fibrosis ( PF ) condition effective therapy remain elusive , make drug trial interventional research study mainstay PF arena last decade foreseeable future . A PF Contact Registry conduit collect , analyze , disseminate de-identified , group-level data clinical phenotype PF patient house contact information patient wish inform research opportunity may qualify . Data contain Registry help inform research hypothesis guide investigator develop research protocol provide number potential subject meet particular inclusion/exclusion criterion .</brief_summary>
	<brief_title>Pulmonary Fibrosis Contact Registry</brief_title>
	<detailed_description>Detailed information find website www.pulmonaryfirbrosisresearch.org . Who Registry ? Anyone least 18 year age , read understand English , either 1. diagnose PF 2. primary supporter caregiver someone live PF How Registry work Patients PF consent enrol Registry may consent contacted Registry personnel opportunity participate research study . Some study ( e.g. , `` Observing Effects Supplemental Oxygen Patients Pulmonary Fibrosis '' ) conduct Dr. Swigris research team—these study consider Registry-affiliated . Registry participant free enroll study wish—whether Registry-affiliated conduct investigator affiliate Registry—i.e. , non-Registry-affiliated study . It assume investigator conduct study adhere regulation govern protection human subject research . Consider hypothetical example : investigator Michigan conduct study effect oral honey PF-related cough would like Registry participant consider enrollment . The investigator would petition Registry , approve Registry Oversight Committee , Registry personnel would contact potentially eligible Registry participant inform study . The participant would decide whether contact investigator Michigan consider enrollment . The investigatory Michigan would responsible discuss study potential subject , obtain informed consent conduct study . All fall outside purview Registry personnel . How subject enroll Registry Eligible participant must fill intake questionnaire/consent form . Contact information provide receive questionnaire store Registry Data Coordinating Center ( DCC ) study coordinator . Subjects may obtain intake questionnaire , complete , submit four different way : - Complete questionnaire/consent form submit online http : //dccweb.njhealth.org/sec/P3F_Swigris/Index.htm . Participants encourage print copy record . - Enter mail address onto online form http : //pulmonaryfibrosisresearch.org/contact hard copy mail subject . Once signed questionnaire/consent send back study coordinator , copy make mail back participant his/her record . - Fill form electronically https : //dccweb.njhealth.org/sec/P3F_Swigris/Index.htm print copy form , print form fill hand mail fax complete questionnaire study coordinator hand DCC National Jewish Health . Participants encourage print copy record . - Call study coordinator toll-free 1-855-609-0010 him/her mail hard copy questionnaire/consent form subject . Once signed questionnaire/consent send back study coordinator , copy make mail back participant his/her record .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<criteria>Anyone selfreports diagnosis pulmonary fibrosis 18 year age include Registry . Anyone selfreports primary supporter caregiver someone live pulmonary fibrosis age 18 include Registry . Whoever consent enrolled Registry presumably able read write English . Failure meet inclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Pulmonary fibrosis</keyword>
	<keyword>Interstitial lung disease</keyword>
	<keyword>Connective tissue disease</keyword>
	<keyword>Chronic hypersensitivity pneumonitis</keyword>
	<keyword>Idiopathic pulmonary fibrosis</keyword>
</DOC>